ID   CP51A_HUMAN             Reviewed;         509 AA.
AC   Q16850; A0A0C4DFL7; A4D1F8; B2RAI4; B4DJ55; O00770; O00772; Q16784; Q8N1A8;
AC   Q99868;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   29-SEP-2021, sequence version 4.
DT   28-JUN-2023, entry version 202.
DE   RecName: Full=Lanosterol 14-alpha demethylase {ECO:0000305};
DE            Short=LDM;
DE            EC=1.14.14.154 {ECO:0000269|PubMed:20149798, ECO:0000269|PubMed:8619637, ECO:0000269|PubMed:9559662};
DE   AltName: Full=CYPLI;
DE   AltName: Full=Cytochrome P450 51A1;
DE            Short=CYP51A1;
DE   AltName: Full=Cytochrome P450-14DM;
DE            Short=Cytochrome P45014DM;
DE   AltName: Full=Cytochrome P450LI;
DE   AltName: Full=Sterol 14-alpha demethylase;
GN   Name=CYP51A1 {ECO:0000312|HGNC:HGNC:2649}; Synonyms=CYP51;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=8619637; DOI=10.1006/abbi.1996.0193;
RA   Stroemstedt M., Rozman D., Waterman M.R.;
RT   "The ubiquitously expressed human CYP51 encodes lanosterol 14 alpha-
RT   demethylase, a cytochrome P450 whose expression is regulated by
RT   oxysterols.";
RL   Arch. Biochem. Biophys. 329:73-81(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=8797093; DOI=10.1093/oxfordjournals.jbchem.a021331;
RA   Aoyama Y., Noshiro M., Gotoh O., Imaoka S., Funae Y., Kurosawa N.,
RA   Horiuchi T., Yoshida Y.;
RT   "Sterol 14-demethylase P450 (P45014DM*) is one of the most ancient and
RT   conserved P450 species.";
RL   J. Biochem. 119:926-933(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Liver;
RX   PubMed=8809088; DOI=10.1006/abbi.1996.0416;
RA   Rozman D., Stroemstedt M., Waterman M.R.;
RT   "The three human cytochrome P450 lanosterol 14 alpha-demethylase (CYP51)
RT   genes reside on chromosomes 3, 7, and 13: structure of the two
RT   retrotransposed pseudogenes, association with a line-1 element, and
RT   evolution of the human CYP51 family.";
RL   Arch. Biochem. Biophys. 333:466-474(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8975714; DOI=10.1006/geno.1996.0640;
RA   Rozman D., Stroemstedt M., Tsui L.-C., Scherer S.W., Waterman M.R.;
RT   "Structure and mapping of the human lanosterol 14alpha-demethylase gene
RT   (CYP51) encoding the cytochrome P450 involved in cholesterol biosynthesis;
RT   comparison of exon/intron organization with other mammalian and fungal CYP
RT   genes.";
RL   Genomics 38:371-381(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9559662; DOI=10.1016/s0014-5793(98)00247-6;
RA   Lamb D.C., Kelly D.E., Kelly S.L.;
RT   "Molecular diversity of sterol 14alpha-demethylase substrates in plants,
RT   fungi and humans.";
RL   FEBS Lett. 425:263-265(1998).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 60-508 IN COMPLEXES WITH HEME;
RP   KETOCONAZOLE AND ECONAZOLE, CATALYTIC ACTIVITY, FUNCTION, AND COFACTOR.
RX   PubMed=20149798; DOI=10.1016/j.jmb.2010.01.075;
RA   Strushkevich N., Usanov S.A., Park H.W.;
RT   "Structural basis of human CYP51 inhibition by antifungal azoles.";
RL   J. Mol. Biol. 397:1067-1078(2010).
CC   -!- FUNCTION: Sterol 14alpha-demethylase that plays a critical role in the
CC       cholesterol biosynthesis pathway, being cholesterol the major sterol
CC       component in mammalian membranes as well as a precursor for bile acid
CC       and steroid hormone synthesis (PubMed:8619637, PubMed:9559662,
CC       PubMed:20149798). Cytochrome P450 monooxygenase that catalyzes the
CC       three-step oxidative removal of the 14alpha-methyl group (C-32) of
CC       sterols such as lanosterol (lanosta-8,24-dien-3beta-ol) and 24,25-
CC       dihydrolanosterol (DHL) in the form of formate, and converts the
CC       sterols to 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol and 4,4-
CC       dimethyl-8,14-cholestadien-3beta-ol, respectively, which are
CC       intermediates of cholesterol biosynthesis (PubMed:8619637,
CC       PubMed:9559662, PubMed:20149798). Can also demethylate susbtrates not
CC       intrinsic to mammals, such as eburicol (24-methylene-24,25-
CC       dihydrolanosterol), but at a lower rate than DHL (PubMed:9559662).
CC       {ECO:0000269|PubMed:20149798, ECO:0000269|PubMed:8619637,
CC       ECO:0000269|PubMed:9559662}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 14alpha-methyl steroid + 3 O2 + 3 reduced
CC         [NADPH--hemoprotein reductase] = a Delta(14) steroid + formate + 4
CC         H(+) + 4 H2O + 3 oxidized [NADPH--hemoprotein reductase];
CC         Xref=Rhea:RHEA:54028, Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:15740, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:138029, ChEBI:CHEBI:138031; EC=1.14.14.154;
CC         Evidence={ECO:0000269|PubMed:20149798, ECO:0000269|PubMed:8619637,
CC         ECO:0000269|PubMed:9559662};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54029;
CC         Evidence={ECO:0000305|PubMed:20149798, ECO:0000305|PubMed:8619637,
CC         ECO:0000305|PubMed:9559662};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=lanosterol + 3 O2 + 3 reduced [NADPH--hemoprotein reductase] =
CC         4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol + formate + 4
CC         H(+) + 4 H2O + 3 oxidized [NADPH--hemoprotein reductase];
CC         Xref=Rhea:RHEA:25286, Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:15740, ChEBI:CHEBI:16521, ChEBI:CHEBI:17813,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210; EC=1.14.14.154;
CC         Evidence={ECO:0000269|PubMed:20149798, ECO:0000269|PubMed:9559662};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:25287;
CC         Evidence={ECO:0000305|PubMed:20149798, ECO:0000305|PubMed:9559662};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=24,25-dihydrolanosterol + 3 O2 + 3 reduced [NADPH--hemoprotein
CC         reductase] = 4,4-dimethyl-8,14-cholestadien-3beta-ol + formate + 4
CC         H(+) + 4 H2O + 3 oxidized [NADPH--hemoprotein reductase];
CC         Xref=Rhea:RHEA:45960, Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:15740, ChEBI:CHEBI:28113, ChEBI:CHEBI:57618,
CC         ChEBI:CHEBI:58210, ChEBI:CHEBI:78904;
CC         Evidence={ECO:0000269|PubMed:8619637, ECO:0000269|PubMed:9559662};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45961;
CC         Evidence={ECO:0000305|PubMed:8619637, ECO:0000305|PubMed:9559662};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 14alpha-methyl steroid + O2 + reduced [NADPH--hemoprotein
CC         reductase] = a 14alpha-hydroxymethyl steroid + H(+) + H2O + oxidized
CC         [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:68060, Rhea:RHEA-
CC         COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:57618,
CC         ChEBI:CHEBI:58210, ChEBI:CHEBI:138029, ChEBI:CHEBI:176901;
CC         Evidence={ECO:0000250|UniProtKB:Q64654};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:68061;
CC         Evidence={ECO:0000250|UniProtKB:Q64654};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 14alpha-hydroxymethyl steroid + O2 + reduced
CC         [NADPH--hemoprotein reductase] = a 14alpha-formyl steroid + H(+) + 2
CC         H2O + oxidized [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:68064,
CC         Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:57618,
CC         ChEBI:CHEBI:58210, ChEBI:CHEBI:176901, ChEBI:CHEBI:176902;
CC         Evidence={ECO:0000250|UniProtKB:Q64654};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:68065;
CC         Evidence={ECO:0000250|UniProtKB:Q64654};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 14alpha-formyl steroid + O2 + reduced [NADPH--hemoprotein
CC         reductase] = a Delta(14) steroid + formate + 2 H(+) + H2O + oxidized
CC         [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:68068, Rhea:RHEA-
CC         COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:15740,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:138031,
CC         ChEBI:CHEBI:176902; Evidence={ECO:0000250|UniProtKB:Q64654};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:68069;
CC         Evidence={ECO:0000250|UniProtKB:Q64654};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=lanosterol + O2 + reduced [NADPH--hemoprotein reductase] = 32-
CC         hydroxylanosterol + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:75103, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16521, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:166806; Evidence={ECO:0000250|UniProtKB:Q64654};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75104;
CC         Evidence={ECO:0000250|UniProtKB:Q64654};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=32-hydroxylanosterol + O2 + reduced [NADPH--hemoprotein
CC         reductase] = 32-oxolanosterol + H(+) + 2 H2O + oxidized
CC         [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:75107, Rhea:RHEA-
CC         COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:57618,
CC         ChEBI:CHEBI:58210, ChEBI:CHEBI:166681, ChEBI:CHEBI:166806;
CC         Evidence={ECO:0000250|UniProtKB:Q64654};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75108;
CC         Evidence={ECO:0000250|UniProtKB:Q64654};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=32-oxolanosterol + O2 + reduced [NADPH--hemoprotein reductase]
CC         = 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol + formate + 2
CC         H(+) + H2O + oxidized [NADPH--hemoprotein reductase];
CC         Xref=Rhea:RHEA:75111, Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:15740, ChEBI:CHEBI:17813, ChEBI:CHEBI:57618,
CC         ChEBI:CHEBI:58210, ChEBI:CHEBI:166681;
CC         Evidence={ECO:0000250|UniProtKB:Q64654};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75112;
CC         Evidence={ECO:0000250|UniProtKB:Q64654};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=24,25-dihydrolanosterol + O2 + reduced [NADPH--hemoprotein
CC         reductase] = 32-hydroxy-24,25-dihydrolanosterol + H(+) + H2O +
CC         oxidized [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:75079,
CC         Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:28113,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:87057;
CC         Evidence={ECO:0000250|UniProtKB:Q64654};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75080;
CC         Evidence={ECO:0000250|UniProtKB:Q64654};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=32-hydroxy-24,25-dihydrolanosterol + O2 + reduced
CC         [NADPH--hemoprotein reductase] = 32-oxo-24,25-dihydrolanosterol +
CC         H(+) + 2 H2O + oxidized [NADPH--hemoprotein reductase];
CC         Xref=Rhea:RHEA:75087, Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:87057,
CC         ChEBI:CHEBI:87060; Evidence={ECO:0000250|UniProtKB:Q64654};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75088;
CC         Evidence={ECO:0000250|UniProtKB:Q64654};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=32-oxo-24,25-dihydrolanosterol + O2 + reduced
CC         [NADPH--hemoprotein reductase] = 4,4-dimethyl-8,14-cholestadien-
CC         3beta-ol + formate + 2 H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:75083, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:15740, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:78904, ChEBI:CHEBI:87060;
CC         Evidence={ECO:0000250|UniProtKB:Q64654};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75084;
CC         Evidence={ECO:0000250|UniProtKB:Q64654};
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000269|PubMed:20149798};
CC   -!- ACTIVITY REGULATION: Inhibited by azalanstat. Inhibited by azole
CC       antifungal agents ketoconazole, itraconazole and fluconazole.
CC       {ECO:0000250|UniProtKB:Q64654}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=29 uM for lanosterol {ECO:0000269|PubMed:9559662};
CC         KM=27 uM for 24,25-dihydrolanosterol {ECO:0000269|PubMed:9559662};
CC         KM=32 uM for eburicol {ECO:0000269|PubMed:9559662};
CC         KM=32 uM for obtusifoliol {ECO:0000269|PubMed:9559662};
CC         Vmax=0.18 nmol/min/nmol enzyme towards lanosterol
CC         {ECO:0000269|PubMed:9559662};
CC         Vmax=0.5 nmol/min/nmol enzyme towards 24,25-dihydrolanosterol
CC         {ECO:0000269|PubMed:9559662};
CC         Vmax=0.22 nmol/min/nmol enzyme towards eburicol
CC         {ECO:0000269|PubMed:9559662};
CC         Vmax=0.44 nmol/min/nmol enzyme towards obtusifoliol
CC         {ECO:0000269|PubMed:9559662};
CC   -!- PATHWAY: Steroid biosynthesis; zymosterol biosynthesis; zymosterol from
CC       lanosterol: step 1/6. {ECO:0000305|PubMed:8619637}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q64654}; Single-pass membrane protein
CC       {ECO:0000255}. Microsome membrane {ECO:0000250|UniProtKB:Q64654};
CC       Single-pass membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q16850-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q16850-2; Sequence=VSP_037413;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed with highest levels in
CC       testis, ovary, adrenal, prostate, liver, kidney and lung.
CC       {ECO:0000269|PubMed:8619637}.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-7 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC50951.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U23942; AAB39951.1; -; mRNA.
DR   EMBL; D55653; BAA09512.1; -; mRNA.
DR   EMBL; U51692; AAC50951.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U51684; AAC50951.1; JOINED; Genomic_DNA.
DR   EMBL; U51685; AAC50951.1; JOINED; Genomic_DNA.
DR   EMBL; U51686; AAC50951.1; JOINED; Genomic_DNA.
DR   EMBL; U51687; AAC50951.1; JOINED; Genomic_DNA.
DR   EMBL; U51688; AAC50951.1; JOINED; Genomic_DNA.
DR   EMBL; U51689; AAC50951.1; JOINED; Genomic_DNA.
DR   EMBL; U51690; AAC50951.1; JOINED; Genomic_DNA.
DR   EMBL; U51691; AAC50951.1; JOINED; Genomic_DNA.
DR   EMBL; AK314205; BAG36881.1; -; mRNA.
DR   EMBL; AK295932; BAG58717.1; -; mRNA.
DR   EMBL; AC000120; AAB46356.1; -; Genomic_DNA.
DR   EMBL; CH236949; EAL24154.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76858.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76859.1; -; Genomic_DNA.
DR   EMBL; BC032322; AAH32322.1; -; mRNA.
DR   CCDS; CCDS55123.1; -. [Q16850-2]
DR   CCDS; CCDS5623.1; -. [Q16850-1]
DR   PIR; JC4759; JC4759.
DR   PIR; S68855; S68855.
DR   RefSeq; NP_000777.1; NM_000786.3. [Q16850-1]
DR   RefSeq; NP_001139624.1; NM_001146152.1. [Q16850-2]
DR   PDB; 3JUS; X-ray; 2.90 A; A/B=60-508.
DR   PDB; 3JUV; X-ray; 3.12 A; A=60-508.
DR   PDB; 3LD6; X-ray; 2.80 A; A/B=60-508.
DR   PDB; 4UHI; X-ray; 2.04 A; A/B/C/D=67-509.
DR   PDB; 4UHL; X-ray; 2.50 A; A/B/C/D/E/F/G/H=67-509.
DR   PDB; 6Q2T; X-ray; 2.80 A; A/B=67-509.
DR   PDB; 6UEZ; X-ray; 1.98 A; A/B=67-509.
DR   PDBsum; 3JUS; -.
DR   PDBsum; 3JUV; -.
DR   PDBsum; 3LD6; -.
DR   PDBsum; 4UHI; -.
DR   PDBsum; 4UHL; -.
DR   PDBsum; 6Q2T; -.
DR   PDBsum; 6UEZ; -.
DR   AlphaFoldDB; Q16850; -.
DR   SMR; Q16850; -.
DR   BioGRID; 107967; 201.
DR   IntAct; Q16850; 21.
DR   MINT; Q16850; -.
DR   STRING; 9606.ENSP00000003100; -.
DR   BindingDB; Q16850; -.
DR   ChEMBL; CHEMBL3849; -.
DR   DrugBank; DB07705; (S)-econazole.
DR   DrugBank; DB01167; Itraconazole.
DR   DrugBank; DB05667; Levoketoconazole.
DR   DrugBank; DB01110; Miconazole.
DR   DrugBank; DB01007; Tioconazole.
DR   DrugCentral; Q16850; -.
DR   GuidetoPHARMACOLOGY; 1374; -.
DR   SwissLipids; SLP:000001162; -.
DR   iPTMnet; Q16850; -.
DR   PhosphoSitePlus; Q16850; -.
DR   SwissPalm; Q16850; -.
DR   BioMuta; CYP51A1; -.
DR   DMDM; 3915660; -.
DR   EPD; Q16850; -.
DR   jPOST; Q16850; -.
DR   MassIVE; Q16850; -.
DR   MaxQB; Q16850; -.
DR   PaxDb; Q16850; -.
DR   PeptideAtlas; Q16850; -.
DR   ProteomicsDB; 61101; -. [Q16850-1]
DR   ProteomicsDB; 61102; -. [Q16850-2]
DR   Antibodypedia; 34871; 298 antibodies from 30 providers.
DR   DNASU; 1595; -.
DR   Ensembl; ENST00000003100.13; ENSP00000003100.8; ENSG00000001630.18. [Q16850-1]
DR   Ensembl; ENST00000450723.5; ENSP00000406757.1; ENSG00000001630.18. [Q16850-2]
DR   GeneID; 1595; -.
DR   KEGG; hsa:1595; -.
DR   MANE-Select; ENST00000003100.13; ENSP00000003100.8; NM_000786.4; NP_000777.1.
DR   UCSC; uc003ulm.5; human. [Q16850-1]
DR   AGR; HGNC:2649; -.
DR   CTD; 1595; -.
DR   DisGeNET; 1595; -.
DR   GeneCards; CYP51A1; -.
DR   HGNC; HGNC:2649; CYP51A1.
DR   HPA; ENSG00000001630; Tissue enhanced (liver).
DR   MalaCards; CYP51A1; -.
DR   MIM; 601637; gene.
DR   neXtProt; NX_Q16850; -.
DR   OpenTargets; ENSG00000001630; -.
DR   Orphanet; 521432; Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome.
DR   PharmGKB; PA27123; -.
DR   VEuPathDB; HostDB:ENSG00000001630; -.
DR   eggNOG; KOG0684; Eukaryota.
DR   GeneTree; ENSGT00930000151026; -.
DR   HOGENOM; CLU_001570_15_0_1; -.
DR   InParanoid; Q16850; -.
DR   OMA; AWTLIEL; -.
DR   OrthoDB; 5474434at2759; -.
DR   PhylomeDB; Q16850; -.
DR   TreeFam; TF105091; -.
DR   BioCyc; MetaCyc:HS00076-MON; -.
DR   BRENDA; 1.14.13.70; 2681.
DR   BRENDA; 1.14.14.154; 2681.
DR   PathwayCommons; Q16850; -.
DR   Reactome; R-HSA-191273; Cholesterol biosynthesis.
DR   Reactome; R-HSA-211976; Endogenous sterols.
DR   Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR   Reactome; R-HSA-9619665; EGR2 and SOX10-mediated initiation of Schwann cell myelination.
DR   SignaLink; Q16850; -.
DR   UniPathway; UPA00770; UER00754.
DR   BioGRID-ORCS; 1595; 21 hits in 1163 CRISPR screens.
DR   ChiTaRS; CYP51A1; human.
DR   EvolutionaryTrace; Q16850; -.
DR   GenomeRNAi; 1595; -.
DR   Pharos; Q16850; Tchem.
DR   PRO; PR:Q16850; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q16850; protein.
DR   Bgee; ENSG00000001630; Expressed in adrenal tissue and 105 other tissues.
DR   ExpressionAtlas; Q16850; baseline and differential.
DR   Genevisible; Q16850; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0020037; F:heme binding; IDA:UniProtKB.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0008398; F:sterol 14-demethylase activity; IDA:UniProtKB.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome.
DR   GO; GO:1900222; P:negative regulation of amyloid-beta clearance; ISS:ARUK-UCL.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; ISS:ARUK-UCL.
DR   GO; GO:0050709; P:negative regulation of protein secretion; ISS:ARUK-UCL.
DR   GO; GO:0006694; P:steroid biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0016125; P:sterol metabolic process; IBA:GO_Central.
DR   CDD; cd11042; CYP51-like; 1.
DR   Gene3D; 1.10.630.10; Cytochrome P450; 1.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002403; Cyt_P450_E_grp-IV.
DR   InterPro; IPR036396; Cyt_P450_sf.
DR   PANTHER; PTHR24304:SF2; 24-HYDROXYCHOLESTEROL 7-ALPHA-HYDROXYLASE; 1.
DR   PANTHER; PTHR24304; CYTOCHROME P450 FAMILY 7; 1.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00465; EP450IV.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; Cytochrome P450; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cholesterol biosynthesis;
KW   Cholesterol metabolism; Endoplasmic reticulum; Heme; Iron;
KW   Lipid biosynthesis; Lipid metabolism; Membrane; Metal-binding; Microsome;
KW   Monooxygenase; Oxidoreductase; Reference proteome; Steroid biosynthesis;
KW   Steroid metabolism; Sterol biosynthesis; Sterol metabolism; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..509
FT                   /note="Lanosterol 14-alpha demethylase"
FT                   /id="PRO_0000051998"
FT   TRANSMEM        30..50
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   BINDING         455
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000269|PubMed:20149798"
FT   VAR_SEQ         1..105
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_037413"
FT   VARIANT         19
FT                   /note="V -> A (in dbSNP:rs2229188)"
FT                   /id="VAR_023470"
FT   CONFLICT        276
FT                   /note="K -> E (in Ref. 5; BAG36881)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        278
FT                   /note="R -> T (in Ref. 4; AAC50951)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        374
FT                   /note="K -> R (in Ref. 4; AAC50951)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        383
FT                   /note="I -> V (in Ref. 9; AAH32322)"
FT                   /evidence="ECO:0000305"
FT   TURN            75..77
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           80..85
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           87..98
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   STRAND          100..106
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   STRAND          109..114
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           117..125
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   TURN            128..130
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   STRAND          131..133
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           134..145
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           150..152
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           155..165
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   TURN            166..168
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           171..189
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           190..192
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   STRAND          194..199
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           200..216
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           219..223
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           229..237
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           242..246
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   STRAND          252..254
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           255..277
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           288..292
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   STRAND          297..299
FT                   /evidence="ECO:0007829|PDB:6Q2T"
FT   HELIX           304..335
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           337..351
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           360..363
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           367..379
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   STRAND          386..392
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   STRAND          394..396
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   STRAND          399..401
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   STRAND          406..409
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           411..414
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   TURN            418..420
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   TURN            422..425
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           429..433
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           437..440
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   STRAND          441..445
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           451..453
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   HELIX           458..475
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   STRAND          476..479
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   STRAND          481..483
FT                   /evidence="ECO:0007829|PDB:3JUV"
FT   STRAND          491..494
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   STRAND          496..499
FT                   /evidence="ECO:0007829|PDB:6UEZ"
FT   STRAND          501..506
FT                   /evidence="ECO:0007829|PDB:6UEZ"
SQ   SEQUENCE   509 AA;  57278 MW;  F9145DDB65F94091 CRC64;
     MAAAAGMLLL GLLQAGGSVL GQAMEKVTGG NLLSMLLIAC AFTLSLVYLI RLAAGHLVQL
     PAGVKSPPYI FSPIPFLGHA IAFGKSPIEF LENAYEKYGP VFSFTMVGKT FTYLLGSDAA
     ALLFNSKNED LNAEDVYSRL TTPVFGKGVA YDVPNPVFLE QKKMLKSGLN IAHFKQHVSI
     IEKETKEYFE SWGESGEKNV FEALSELIIL TASHCLHGKE IRSQLNEKVA QLYADLDGGF
     SHAAWLLPGW LPLPSFRRRD RAHREIKDIF YKAIQKRRQS QEKIDDILQT LLDATYKDGR
     PLTDDEVAGM LIGLLLAGQH TSSTTSAWMG FFLARDKTLQ KKCYLEQKTV CGENLPPLTY
     DQLKDLNLLD RCIKETLRLR PPIMIMMRMA RTPQTVAGYT IPPGHQVCVS PTVNQRLKDS
     WVERLDFNPD RYLQDNPASG EKFAYVPFGA GRHRCIGENF AYVQIKTIWS TMLRLYEFDL
     IDGYFPTVNY TTMIHTPENP VIRYKRRSK
//
